JLL says time not right to sell Patheon

JLL says time not right to sell Patheon
Reuters - 17 hours ago
By Pav Jordan and Scott Anderson TORONTO (Reuters) - Patheon Inc's (PTI.TO) majority owner says it is not interested in selling the drug manufacturer to Switzerland's Lonza (LONN.VX) and has no ...
Lonza submits non-binding proposal to acquire all Patheon Inc Restricted Voting Shares for USD 3.55 per share - pharmabiz.com
Swiss Pharma Supplier Lonza Bids for Canada's Patheon - IndustryWeek
OutSourcing-Pharma.com
- NPIcenter
- Emii.com